3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Anemia, Refractory, with Excess of Blasts
2
Shwachman-Diamond Syndrome
1
Recurrence
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hemoglobinuria, Paroxysmal
1
Hematologic Neoplasms
1
Congenital amegakaryocytic thrombocytopenia
1
Bone Marrow Failure Disorders
1
Anemia, Hypochromic
1
Anemia, Diamond-Blackfan
1
Interventions
Nivolumab
39
pembrolizumab
30
cabozantinib
29
Specimen Handling
25
Magnetic Resonance Spectroscopy
22
Ipilimumab
20
lenvatinib
16
Axitinib
15
belzutifan
13
CTLA-4 Antigen
10
Sunitinib
9
Biopsy
9
Radiosurgery
8
atezolizumab
7
Immunoglobulin G
5
toripalimab
4
fludarabine
4
avelumab
4
aldesleukin
4
Everolimus
4
Disulfides
4
Cyclophosphamide
4
zimberelimab
3
tivozanib
3
spartalizumab
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Antilymphocyte Serum
×
90 days
×
Clear all
No trials found.